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Abstract: An efficient and stereoselective synthesis of a new 
deuterium-labeled phytol as a useful tracer in biosynthetic 
processes is presented.  
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Phytol ((E)-3,7,11,15-tetramethyl-2-hexadecen-1-ol) 
is an acyclic diterpene alcohol that occurs as a side 
chain of chlorophyll and is therefore abundantly 
present in nature, not only in plants but also in the 
animal kingdom. On being digested, the phytol moiety 
is released and can then be converted into other 
important metabolites, such as phytanic acid 
(3,7,11,15-tetramethylhexadecanoic acid), whose 
accumulation in human blood and tissues has been 
linked to neurological disorders, peroxisomal 
biogenesis diseases, and apoptosis.
1
 In addition, 
phytol can be used as a precursor of vitamins E
2
 and 
K1
3
 and its balsamic properties are greatly appreciated 
in the fragrance industry, where it is used in 
approximately 0.1-1.0 metric tons per year.
4
 
Therefore, the preparation of new isotopically labeled 
phytol derivatives is important because they could be 
potentially useful in a number of relevant biological 
processes.
5
 
In the course of our investigations aimed at the 
structural characterization of a bioactive natural 
compound (to be published), phytol appeared to be the 
most plausible biosynthetic precursor. Therefore, 
synthesis of a labeled analogue of phytol with the 
labeling far enough from the oxygenated function to 
avoid it being affected in the biosynthetic process was 
required. As is well known, isotopic labeling is a very 
useful technique for tracking the transformations 
undergone by a certain molecule or the mechanisms 
involved in many biochemical processes.
6
 
Few labeled phytols (1-4) have been described so far 
in the literature.
5,7
 Most of these derivatives, 
particularly 1-2 (Scheme 1), contained the label at 
positions that can be also affected in the biosynthetic 
processes, and compound 4 was part of a mixture of 
differently labeled compounds.
7c
 For these reasons, a 
more suitable labeled phytol, compound 5 with two 
deuterium atoms at C-5 away from the functionalized 
end of the molecule, was considered for our study. 
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Scheme 1  
The strategy for the preparation of 5 was based on a 
straightforward approach by the regioselective 
opening of 3,4-epoxyisoprene with the appropriate 
labeled Grignard reagent. 3,4-epoxyisoprene can be 
obtained in a single step and with reasonable yield 
from methacrolein by selective 1,2-addition of 
dimethylsulphonium methylide.
8
 For preparation of 
the other labeled building block 10, farnesol (6) was 
initially treated with hydrogen and 10% Pd/C to 
obtain the corresponding hexahydrofarnesol (7) but 
the hydrogenolysis product farnesane was recovered 
almost exclusively. However, successful 
hydrogenation was achieved by using Pt/C as catalyst 
to provide the fully hydrogenated compound in 
quantitative yield.
9
 Oxidation of compound 7 under 
standard conditions (CrO3/H2SO4) furnished acid 8, 
which was quantitatively reduced to the corresponding 
deuterated alcohol 9 with LiAlD4. In this process, no 
trace of the mono- or non-labeled alcohol was 
detected, as demonstrated by the absence of the 
characteristic signal at 3.67 ppm in the 
1
H-NMR 
spectrum. The alcohol 9 was transformed into the 
corresponding bromide 10 by treatment with 
Ph3P/NBS
10a
 in CH2Cl2 in 95% yield. Reaction of 10 
with freshly activated Mg turnings in THF,
10a,b
 
followed by treatment with a catalytic amount of CuI 
and finally with 3,4-epoxyisoprene at -78ºC yielded 
the expected compound 5 stereoselectively as the E 
isomer (E:Z; 96:4), the isomer corresponding to 
natural phytol, in a reasonable 45% yield. We have 
noticed that an excess of Mg is required in this 
reaction to avoid the homo-coupling reaction. It is 
worthy of note that this synthetic strategy ensures the 
introduction of two deuterium atoms in a pre-defined 
position of the molecule, avoiding problematic 
mixtures of differently labeled compounds. 
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Scheme 2  
In conclusion, we have accomplished the synthesis of 
a new labeled phytol with two deuterium atoms at C-
5, far enough from the functionalized end of the 
molecule, which makes it an attractive candidate for a 
variety of biosynthetic studies. The synthesis is short, 
stereoselective and with a good overall yield (16.6%) 
from readily available starting materials. 
 
All reactions involving air or moisture sensitive 
materials were carried out under Ar. All solvents were 
dried and distilled according to standard procedures. 
Location of deuterium atoms and purity of the labeled 
compounds was determined by elemental analysis, 
MS, and NMR. NMR spectra were recorded at 400 
MHz for 
1
H and 100 MHz for 
13
C on a Varian 
Mercury 400 MHz spectrometer. IR spectra were 
recorded on a Nicolet Avatar 360 FT-IR spectrometer. 
MS were run in electron impact (EI) mode (70 eV) 
and obtained on a Fisons MD 800 instrument. 
Elemental analyses were determined on a Carlo Erba 
1108 and on a Metrohm Titrando 808 analyser. HRMS 
was run on a UPLC Acquity (Waters, USA) coupled 
to a mass spectrometer LCT Premier XE (Waters, 
USA). 
3,4-Epoxy-2-methyl-1-butene
8 
To a stirred suspension of methyltrimethylsulphonium 
sulphate (6.14 g, 32.63 mmol) and sodium hydroxide 
(7.10 g, 0.18 mol) in anh. CH2Cl2 (70 ml), was added 
methacrolein (2.4 ml, 28.5 mmol) in 4 portions over a 
period of 20 min. After 4 h of stirring at room 
temperature, water was added and the organic layer was 
separated and dried (MgSO4). After filtration, the crude 
product was purified by distillation at atmospheric 
pressure, collecting the material with a boiling point of 
90 °C to obtain pure 3,4-epoxy-2-methyl-1-butene as a 
colorless liquid (1.32 g, 55%). 
1
H NMR (400 MHz, 
CDCl3): δ 5.16 (m, 1H); 5.01 (m, 1H); 3.36 (m, 1H); 
2.85 (m, 1H); 2.71 (m, 1H); 1.61 (m, 3H) ppm. 
13
C NMR 
(100 MHz, CDCl3): δ 141.3 (C); 114.5 (CH2); 54.4 (CH); 
46.6 (CH2); 16.0 (CH3) ppm.  
3,7,11-Trimethyldodecan-1-ol (7)
11 
A solution of farnesol (6) (5.00 g; 22.52 mmol) in EtOH 
(25 ml) was subjected to hydrogenation at atmospheric 
pressure using 10% Pt/C (200 mg) as catalyst.
9
 After 12 
h of stirring at room temperature, the reaction was 
completed. The crude product was filtered on Celite and 
the solvent evaporated to yield the saturated alcohol 7 
(5.13 g, 99%) as a colorless oil, pure enough for the next 
step of the synthesis without need of further purification. 
1
H NMR (400 MHz, CDCl3): δ 3.67 (m, 2H); 1.55 (b, 
3H); 1.01-1.38 (b, 14H); 0.86 (m, 12H) ppm. 
13
C NMR 
(100 MHz, CDCl3): δ 61.2 (CH2); 40.0 (CH2); 39.3 
(CH2); 37.5 (CH2); 37.4 (CH2); 37.3 (CH2); 32.8 (CH); 
29.5 (CH); 27.9 (CH); 24.8 (CH2); 24.4 (CH2); 22.7 
(CH3); 22.6 (CH3); 19.7 (CH3); 19.6 (CH3) ppm. IR 
(film) ν: 3349, 2955, 2927, 2869, 1463, 1378, 1056, 908, 
735 cm
-1
. MS (EI) m/z (%): 210 [(M-18)
+
, 1]; 182 (13); 
140 (28); 125 (88); 111 (84); 97 (91); 83 (91); 69 (100); 
57 (97); 43 (82). 
3,7,11-Trimethyldodecanoic acid (8)
12
 
To a solution of alcohol 7 (3.00 g, 13.0 mmol) in acetone 
(75 ml), was added at 0 °C a solution of Jones reagent 
prepared from 3.19 g of CrO3, 2.6 ml of H2SO4 conc., 
and 9 ml H2O until the reaction mixture turned red. After 
4 h of stirring at 0 ºC, 2-propanol was added to stop the 
reaction, the solvent was evaporated and the residue was 
purified on column chromatography, eluting with a 
mixture of hexane:Et2O 99:1, to obtain acid 8 (2.28 g, 
72%) as a pale yellow oil. 
1
H NMR (400 MHz, CDCl3): 
δ 2.37 (m, 1H); 2.14 (m, 1H); 1.96 (m, 1H); 1.52 (m, 
1H); 1.05-1.38 (b, 13H); 0.97 (d, J = 8.0 Hz, 3H); 0.86 
(d, J = 8.0 Hz, 6H); 0.84 (d, J = 8.0 Hz, 3H) ppm. 13C 
NMR (100 MHz, CDCl3): δ 179.7 (C);  41.6 (CH2); 39.3 
(CH2); 37.3 (CH2); 37.1 (CH2); 37.0 (CH2); 32.7 (CH); 
30.2 (CH); 28.0 (CH); 24.8 (CH2); 24.3 (CH2); 22.7 
(CH3); 22.6 (CH3); 19.7 (CH3); 19.6 (CH3) ppm. IR 
(film) ν: 3084, 2955, 2927, 2678, 1709, 1463, 1298, 937 
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cm
-1
. MS (EI) m/z (%): 242 (M
+
, 3); 227 (2); 180 (30); 
157 (57); 139 (39); 111 (45); 97 (79); 87 (100); 71 (84); 
57 (87); 43 (68). 
[1,1-
2
H2]-3,7,11-Trimethyldodecan-1-ol (9) 
To a suspension of LiAlD4 (0.41 g, 9.8 mmol) in anh. 
Et2O (10 ml) was slowly added a solution of 8 (1.58 g, 
6.5 mmol) in anh. Et2O (10 ml) at 0 °C. The reaction 
mixture was then refluxed until complete consumption of 
10 (3 h). The reaction mixture was cooled to 0 °C and 
quenched with 0.4 ml of H2O, 0.4 ml of a 15% aq. soln. 
NaOH and 1.2 ml of H2O. The salts were filtered and the 
solvent removed under vacuum to provide alcohol 9 (1.5 
g, 99%) as a pale yellow oil, pure enough for the next 
step of the synthesis without need of further purification. 
1
H NMR (400 MHz, CDCl3): δ 1.47-1.61 (b, 3H); 1.01-
1.41 (b, 14H); 0.87 (m, 12H) ppm. 
13
C NMR (100 MHz, 
CDCl3): δ 60.51 (quint, J = 21.0 Hz, CD2); 39.8 (CH2); 
39.3 (CH2); 37.4 (CH2); 37.3 (CH2); 37.2 (CH2); 32.8 
(CH); 29.4 (CH); 27.9 (CH); 24.8 (CH2); 24.3 (CH2); 
22.7 (CH3); 22.6 (CH3); 19.7 (CH3); 19.6 (CH3) ppm. IR 
(film) ν: 3335, 2955, 2926, 2869, 1463, 1378, 969, 908, 
736 cm
-1
. MS (EI) m/z (%): 230 (M
+
, 1); 212 (2); 182 
(12); 142 (27); 127 (87); 111 (78); 99 (77); 85 (84); 71 
(100); 57 (98); 43 (82). Elemental analysis: Calcd for 
C15H30D2O: C, 78.19; H, 14.87. Found: C, 78.34; H, 
14.50. 
[1,1-
2
H2]-1-Bromo-3,7,11-trimethyldodecane (10) 
N-Bromosuccinimide (1.31 g, 7.4 mmol) was added 
portionwise over 30 min to a solution of 9 (1.50 g, 6.5 
mmol) and triphenylphosphine (2.05 g, 7.8 mmol) in 
anh. CH2Cl2 (10 ml) at 0 °C
10a
. The reaction mixture was 
stirred for 30 min and then concentrated under reduced 
pressure. Purification on SiO2 column chromatography 
eluting with hexane afforded compound 10 (1.82 g, 95%) 
as a colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 1.87 
(m, 1H); 1.50-1.67 (b, 3H); 1.08-1.37 (b, 13H), 0.87 (m, 
12H) ppm. 13C NMR (100 MHz, CDCl3): δ 39.8 (CH2); 
39.4 (CH2); 37.4 (CH2); 37.3 (CH2); 36.8 (CH2); 32.8 
(CH); 31.7 (quint, J = 22.0 Hz, CD2); 31.6 (CH); 28.0 
(CH); 24.8 (CH2); 24.2 (CH2); 22.7 (CH3); 22.6 (CH3); 
19.7 (CH3); 19.0 (CH3) ppm. IR (film) ν: 3006, 2925, 
2860, 1462, 1251, 908, 736 cm-1. MS (EI) m/z (%): 294 
[(M+1)
+
, 1]; 292 [(M-1)
+
, 1]; 279 (3); 277 (3); 209 (36); 
207 (38); 181 (28); 179 (29); 167 (27); 165 (28); 153 
(44); 151 (46); 127 (62); 113 (79); 99 (42); 97 (44); 85 
(72); 71 (100); 57 (99); 43 (43). Elemental analysis: 
Calcd for C15H29D2Br: C, 61.42; H, 11.34; Br, 27.24. 
Found: C, 61.36; H, 10.98; Br, 27.03. 
[5,5-
2
H2]-(E)-3,7,11,15-tetramethyl-2-hexadecen-1-ol 
(5) 
1,2-Dibromoethane (32 µl, 0.37 mmol) was added to a 
suspension of Mg turnings (0.19 g, 7.8 mmol) in anh. 
THF (1.5 ml). The mixture was stirred at 50 °C for 15 
min, the solvent was removed by syringe and the black 
activated turnings were suspended again in anh. THF 
(1.5 ml). A solution of 10 (0.57 g, 1.9 mmol) in anh. THF 
(1.5 ml) was slowly added and the mixture was stirred at 
room temperature for 2 h. The Grignard reagent solution 
of 10 was added at -78 °C via cannula to a second flask 
containing a suspension of CuI (15 mg, 97 µmol) in THF 
(1.5 ml). The reaction mixture was stirred at -78 °C for 5 
min. Then, 3,4-epoxyisoprene (0.19 g, 2.3 mmol) was 
added and after additional stirring for 5 min at -78 °C, 
the mixture was allowed to warm to room temperature 
for 1 h. After this time, the solvent was removed under 
reduced pressure and the crude was directly purified by 
column chromatography on SiO2 eluting with a mixture 
of hexane:Et2O 4:1 to afford alcohol 5 (0.26 g, 45%, E:Z 
= 96:4) as a colorless oil. 
1
H NMR (400 MHz, CDCl3): δ 
5.40 (m, 1H); 4.14 (d, J = 8.0 Hz, 2H); 1.97 (s, 2H); 1.66 
(s, 3H); 1.52 (m, 1H); 1.00-1.39 (b, 17H); 0.85 (m, 12H) 
ppm. 
13
C NMR (100 MHz, CDCl3): δ 140.2 (C); 123.1 
(CH); 59.4 (CH2); 39.7 (CH2); 39.4 (CH2); 37.4 (CH2); 
37.3 (CH2); 37.2 (CH2); 36.5 (CH2); 32.8 (CH); 32.6 
(CH); 28.0 (CH); 24.8 (CH2); 24.5 (CH2); 22.7 (CH3); 
22.6 (CH3); 19.7 (CH3); 19.6 (CH3); 16.2 (CH3) ppm. IR 
(film) ν: 3329, 2954, 2925, 2869, 1463, 1378, 1002 
cm-1. MS (EI) m/z (%): 298 (M+, 1); 280 (6); 139 (18); 
125 (52); 111 (47); 97 (56); 84 (58); 71 (100); 57 (58); 
43 (56). HRMS Calcd for C20H39D2O (M+1)
+
: 299.3283; 
Found: 299.3283. 
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